Trial intelligence / Profile preview

Remimazolam vs propofol for induction in elderly undergoing upper abdominal surgery

ChiCTR2100044570Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Mar 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Hemodynamic variability, Anesthesia recovery time and 1 more. Started Mar 2021; status: recruiting.

02

Drugs

remimazolam

Beyond the preview

Go deeper on ChiCTR2100044570.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100044570.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call